Clear Street Markets LLC Seagen Inc. Call Options Transaction History

Clear Street Markets LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	BUY	$0.0 - $228.9 $0 - $961,380	4,200 Added 0.91%	467,500 $107 Million
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $5.84 Million - $6.59 Million	-30,500 Reduced 6.18%	463,300 $98.3 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $86.6 Million - $95.1 Million	461,300 Added 1419.38%	493,800 $95 Million
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $2.55 Million - $4.06 Million	20,000 Added 160.0%	32,500 $6.58 Million
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $5.87 Million - $6.96 Million	-50,000 Reduced 80.0%	12,500 $1.61 Million
Q3 2022 Nov 02, 2022	BUY	$135.27 - $180.11 $8.36 Million - $11.1 Million	61,800 Added 8828.57%	62,500 $8.55 Million
Q2 2022 Aug 02, 2022	BUY	$108.81 - $179.33 $76,167 - $125,531	700 New	700 $124,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.